NeoGenomics, Inc. Convertible Notes Payable, Current
NeoGenomics, Inc. (NEO) had Convertible Notes Payable, Current of $0 as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleNotesPayableCurrent · last filed 2026-02-17
- 2025-12-31: Convertible Notes Payable, Current $0.00.
- 2025-09-30: Convertible Notes Payable, Current $0.00.
- 2025-06-30: Convertible Notes Payable, Current $0.00.
- 2025-03-31: Convertible Notes Payable, Current $201.13M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-17 |
| 2025-09-30 | $0.00 10-Q · filed 2025-10-28 |
| 2025-06-30 | $0.00 10-Q · filed 2025-07-29 |
| 2025-03-31 | $201.13M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $200.78M 10-K · filed 2026-02-17 |
| 2024-09-30 | $200.42M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $200.07M 10-Q · filed 2024-07-30 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |